Value of Computed Tomography and Fluorodeoxyglucose-Positron Emission Tomography Imaging for Preoperative Screening in Advanced Heart Failure Therapies Candidates

X. Rabbath,M. Pelletier-Galarneau,M. Tremblay-Gravel,P. Noly,N. Racine,S. Tan

DOI: https://doi.org/10.1016/j.healun.2022.01.1455

IF: 13.569

2022-04-01

The Journal of Heart and Lung Transplantation

Abstract:Purpose Careful selection of candidates for advanced heart failure therapies is paramount for the optimal allocation of resources. Since the value of computed tomography (CT) and fluorodeoxyglucose-positron emission tomography (FDG-PET) in this context remains unclear, imaging workup for these patients varies from one center to another. The objectives of this study are to assess the impact of CT and FDG-PET/CT in the evaluation of heart transplant (HTx) or ventricular assist devices (VAD) candidates and to assess the added value of FDG-PET/CT when performed following CT. Methods All the patients assessed for HTx or VAD in our institution between 2014 and 2021 were reviewed. Patients who underwent contrast-enhanced chest and abdominal CT and FDG-PET/CT within a 6 month-interval were included in the study. Imaging reports were reviewed for significant findings, defined as possible contraindications for HTx/VAD, having an impact on their medical or surgical management, or actionable findings. Medical records were also reviewed for subsequent diagnostic investigations and for the multidisciplinary team's final decision. Results In the 79 included patients, significant findings were found in 37 patients (46,8%) with CT and in 18 patients (22,8%) with FDG-PET/CT (p=.0015). Significant findings on CT were more frequently vascular-related than significant findings on FDG-PET/CT (39% vs 6%; p=.01), but significant findings of both modalities were equally suspicious of cancer (61% vs 42%; p=.19), infection (28% vs 11%; p=.11) and other findings (8% vs 17%; p=.32). Of the significant findings identified on FDG-PET/CT, 56% were not identified on CT. Finally, 4 patients had imaging findings precluding HTx/VAD; 2 cases were identified on both CT and FDG-PET/CT and 2 cases were identified on CT only (peripheral arterial disease). Conclusion The difference in proportions of imaging studies with significant findings between CT and FDG-PET/CT favored the use of CT. Thus, our study suggests that both CT and FDG-PET/CT may have a value in pre-assessment of candidates for advanced heart failure therapies. A progressive approach consisting of CT followed by FDG-PET/CT as needed may be a reasonable work-up strategy. Further studies are needed to confirm these findings.